An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Thyroid Eye Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Applied Research Center of Arkansas, Little Rock, Arkansas, United States

  • Ilumina Medical Research, Kissimmee, Florida, United States

  • Eb Group Spolka z ograniczona odpowiedzialnoscia, Warsaw, Poland

  • Hospital Universitario Virgen Macarena, Seville, Andalusia, Spain

  • Hospital Universitari i Politecnic La Fe, Valencia, Spain

  • National Taiwan University Hospital, Taipei, Taiwan

Study leads
  • MD

    Study Director

    Amgen